Robert J Bernstein, MD
Pulmonary Disease · Ventura
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 39 years
- Temple University School of Medicine, 1987
Offices
2 locations · Community Memorial Health System · Ventura Pulmonary and Critical Care Medical Group
Hospitals listed: Community Memorial Hospital - Ojai · Community Memorial Hospital - Ventura. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bernstein’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence G65091 · Current
Licensed to practise in California · since 1989 · expires 2028-04-30 · Temple University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Critical Care Medicine
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Pulmonary Disease
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Community Memorial Hospital - OjaiOjai, CACritical Access Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Community Memorial Health System, which runs 2 hospitals82% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
- Community Memorial Hospital - VenturaVentura, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Memorial Health System, which runs 2 hospitalsPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.478, Oct 2024 – Sep 2025
See every measure and the patient survey for Community Memorial Hospital - Ojai
Behind the star rating — Deaths: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 0 better, 1 the same, 0 worse of 1 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 28 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 74 cases | None | Jul 2024 – Jun 2025 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -36.9 · 29 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 31 cases | None | Jul 2023 – Jun 2025 |
| Room was "always" clean | 86% |
| Nurses "always" communicated well | 83% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 65% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 81% |
| Nurses "always" treated them with courtesy and respect | 93% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 82% |
| Staff "always" explained possible side effects | 52% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Community Memorial Hospital - Ventura
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 11 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.478 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.95) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.82 (0.49 to 1.15) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 147.27 (93.9 to 200.65) · 66 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 86 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 120 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 273 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.8 · 363 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 3,592 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.36) · 5,727 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.1 to 0.49) · 5,976 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.6 (1.57 to 5.64) · 1,733 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.39 (0 to 2.97) · 688 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.97 (1.53 to 4.4) · 1,669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.87 (1.2 to 14.54) · 661 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.35 to 8.61) · 686 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.94 (0.47 to 3.41) · 327 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.19 (0 to 0.93) · 3,678 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3 · 218 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.548 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.157 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.228 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.373 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14 · 249 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.8 · 649 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -0.8 · 157 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -40.6 · 357 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -5 · 407 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 619 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.4 to 8) · 109 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9 (6.1 to 13) · 109 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10 · 90 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 164 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.2 (8.7 to 14.7) · 1,178 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 986 cases | No different | Jan 2024 – Dec 2024 |
What patients said (949 patients answered, 21% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 61% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$108,207
Medicare paid this office $108,207 for 375 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 211 | $46,406 | $106 |
| Short return visit (20+ min) | 141 | $12,417 | $66 |
| Test to measure rate of airflow | 173 | $6,459 | $33 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 47 | $6,106 | $64 |
| Critical care, first 30-74 minutes | 20 | $5,988 | $166 |
See all 13 services
| Return visit (30+ min) | 211 | $46,406 | $106 |
| Short return visit (20+ min) | 141 | $12,417 | $66 |
| Test to measure rate of airflow | 173 | $6,459 | $33 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 47 | $6,106 | $64 |
| Critical care, first 30-74 minutes | 20 | $5,988 | $166 |
| Long return visit (40+ min) | 33 | $5,271 | $146 |
| New patient visit (45+ min) | 33 | $4,544 | $138 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $4,037 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $3,668 | $131 |
| Test to examine how well the lungs exchange gases | 74 | $3,545 | $46 |
| New patient visit (60+ min) | 14 | $2,617 | $187 |
| Test to determine lung volumes using sensors | 46 | $2,150 | $46 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $560 | $40 |
Who their Medicare patients are
375 Original Medicare patients in 2024. Average age 77 · Under 65 4% · 85 and older 18% · Women 58% · Also on Medicaid 12% · Health risk score 1.91. At or below the middle of the specialty; the typical pulmonary disease clinician is at 2.13.
Conditions among them: High blood pressure 75% · COPD 54% · Coronary heart disease 40% · Depression 34% · Heart failure 31% · Atrial fibrillation 31% · Chronic kidney disease 29% · Diabetes 24% · Cancer 24% · Stroke 14% · Dementia 10%.
The office billed $172,741, Medicare allowed $142,773 and paid $108,207; for 1,312 services of 29 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 375 | 1,312 | 77 | 1.91 | $172,741 | $108,207 |
| 2023 | 382 | 1,441 | 77 | 1.80 | $184,296 | $113,174 |
| 2022 | 360 | 1,319 | 76 | 1.79 | $168,567 | $106,342 |
| 2021 | 384 | 1,437 | 76 | 1.74 | $190,340 | $120,632 |
| 2020 | 387 | 1,441 | 75 | 2.05 | $196,849 | $113,089 |
| 2019 | 406 | 1,889 | 76 | 1.93 | $195,068 | $137,752 |
| 2018 | 404 | 1,842 | 76 | 1.92 | $201,088 | $130,307 |
| 2017 | 409 | 1,911 | 76 | 1.83 | $185,803 | $128,072 |
| 2016 | 417 | 1,907 | 76 | 1.84 | $192,590 | $135,194 |
| 2015 | 406 | 1,882 | 76 | 1.84 | $193,534 | $139,684 |
| 2014 | 396 | 1,833 | 76 | 2.14 | $199,778 | $139,151 |
| 2013 | 389 | 1,909 | 76 | 2.07 | $199,520 | $146,081 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Return visit (30+ min) | 193 | $34,004 | $100 |
| Short return visit (20+ min) | 176 | $17,807 | $69 |
| Critical care, first 30-74 minutes | 34 | $12,403 | $175 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 54 | $8,496 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $7,075 | $98 |
| Test to measure rate of airflow | 182 | $6,483 | $32 |
| Test to examine how well the lungs exchange gases | 108 | $5,655 | $49 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $4,871 | $143 |
| New patient visit (45+ min) | 25 | $3,454 | $138 |
| Test to determine lung volumes using sensors | 72 | $3,442 | $48 |
| Long return visit (40+ min) | 15 | $2,264 | $141 |
| New patient visit (60+ min) | 11 | $1,963 | $178 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 27 | $1,588 | $41 |
| Short return visit | 14 | $594 | $37 |
2022: 14 services
| Return visit (30+ min) | 148 | $26,741 | $104 |
| Short return visit (20+ min) | 170 | $20,713 | $75 |
| Critical care, first 30-74 minutes | 31 | $10,888 | $185 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 49 | $8,642 | $163 |
| Test to measure rate of airflow | 174 | $6,711 | $33 |
| Test to examine how well the lungs exchange gases | 110 | $6,267 | $51 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $5,658 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $4,896 | $58 |
| New patient visit (45+ min) | 27 | $3,706 | $137 |
| Long return visit (40+ min) | 20 | $3,003 | $150 |
| Test to determine lung volumes using sensors | 57 | $2,824 | $50 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $1,034 | $74 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 19 | $849 | $33 |
| Short return visit | 17 | $803 | $45 |
2021: 15 services
| Return visit (30+ min) | 159 | $27,904 | $107 |
| Critical care, first 30-74 minutes | 44 | $19,304 | $184 |
| Short return visit (20+ min) | 167 | $17,017 | $74 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 64 | $8,731 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $7,403 | $168 |
| Test to examine how well the lungs exchange gases | 121 | $6,872 | $54 |
| Test to measure rate of airflow | 172 | $6,608 | $35 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $5,868 | $88 |
| New patient visit (45+ min) | 32 | $4,855 | $152 |
| Test to determine lung volumes using sensors | 62 | $3,118 | $50 |
| Long return visit (40+ min) | 18 | $2,864 | $151 |
| Telephone medical discussion with physician, 11-20 minutes | 31 | $1,404 | $45 |
| Short return visit | 24 | $1,171 | $47 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 19 | $894 | $33 |
| Telephone medical discussion with physician, 5-10 minutes | 15 | $338 | $23 |
2020: 16 services
| Return visit (30+ min) | 189 | $26,445 | $85 |
| Critical care, first 30-74 minutes | 52 | $20,988 | $184 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 76 | $9,609 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $9,198 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 54 | $8,166 | $88 |
| Short return visit (20+ min) | 89 | $6,053 | $58 |
| Test to examine how well the lungs exchange gases | 111 | $5,641 | $48 |
| Test to measure rate of airflow | 152 | $5,449 | $33 |
| Telephone medical discussion with physician, 11-20 minutes | 40 | $3,121 | $66 |
| New patient visit (60+ min) | 18 | $3,092 | $172 |
| Long return visit (40+ min) | 20 | $2,443 | $116 |
| New patient visit (45+ min) | 17 | $2,297 | $135 |
| Test to determine lung volumes using sensors | 46 | $2,257 | $47 |
| Test to measure largest amount of air breathed in an out | 50 | $974 | $19 |
| Telephone medical discussion with physician, 5-10 minutes | 22 | $856 | $37 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 19 | $710 | $32 |
2019: 14 services
| Return visit (30+ min) | 238 | $45,775 | $84 |
| Critical care, first 30-74 minutes | 46 | $21,517 | $185 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 71 | $9,678 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $8,573 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $8,055 | $88 |
| Test to measure rate of airflow | 207 | $8,020 | $34 |
| Test to examine how well the lungs exchange gases | 146 | $7,497 | $46 |
| Test to measure largest amount of air breathed in an out | 183 | $5,096 | $25 |
| New patient visit (60+ min) | 31 | $4,736 | $153 |
| Long return visit (40+ min) | 30 | $3,734 | $110 |
| Test to determine lung volumes using sensors | 72 | $3,292 | $46 |
| Short return visit (20+ min) | 48 | $3,203 | $59 |
| New patient visit (45+ min) | 17 | $2,126 | $125 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 24 | $1,066 | $31 |
2018: 14 services
| Return visit (30+ min) | 232 | $38,738 | $81 |
| Critical care, first 30-74 minutes | 55 | $22,593 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 77 | $8,973 | $58 |
| Test to measure rate of airflow | 201 | $8,059 | $33 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $7,207 | $85 |
| Test to examine how well the lungs exchange gases | 136 | $7,004 | $45 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $6,475 | $158 |
| Short return visit (20+ min) | 101 | $5,761 | $52 |
| Test to measure largest amount of air breathed in an out | 164 | $4,435 | $23 |
| Long return visit (40+ min) | 39 | $4,435 | $114 |
| New patient visit (60+ min) | 24 | $3,973 | $166 |
| Test to determine lung volumes using sensors | 64 | $2,937 | $46 |
| New patient visit (45+ min) | 17 | $2,058 | $121 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 22 | $1,112 | $32 |
2017: 14 services
| Return visit (30+ min) | 216 | $36,241 | $81 |
| Critical care, first 30-74 minutes | 54 | $18,485 | $176 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 87 | $11,441 | $58 |
| Test to measure rate of airflow | 207 | $8,359 | $33 |
| Short return visit (20+ min) | 118 | $8,290 | $55 |
| Test to examine how well the lungs exchange gases | 130 | $6,925 | $45 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 40 | $6,396 | $160 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 37 | $6,119 | $85 |
| New patient visit (60+ min) | 36 | $5,791 | $161 |
| Test to measure largest amount of air breathed in an out | 165 | $4,436 | $22 |
| Long return visit (40+ min) | 33 | $3,934 | $112 |
| Test to determine lung volumes using sensors | 60 | $2,749 | $44 |
| New patient visit (45+ min) | 17 | $1,910 | $112 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 38 | $1,644 | $32 |
2016: 13 services
| Return visit (30+ min) | 227 | $39,057 | $82 |
| Critical care, first 30-74 minutes | 51 | $16,244 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 52 | $11,886 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 66 | $10,897 | $163 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 88 | $10,595 | $58 |
| Test to measure rate of airflow | 197 | $7,942 | $33 |
| Short return visit (20+ min) | 86 | $6,458 | $54 |
| Test to examine how well the lungs exchange gases | 105 | $5,318 | $43 |
| New patient visit (60+ min) | 31 | $4,820 | $155 |
| Test to measure largest amount of air breathed in an out | 153 | $3,897 | $22 |
| Long return visit (40+ min) | 29 | $3,608 | $120 |
| Test to determine lung volumes using sensors | 51 | $2,242 | $44 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 36 | $1,713 | $32 |
2015: 16 services
| Return visit (30+ min) | 213 | $40,690 | $85 |
| Critical care, first 30-74 minutes | 59 | $22,242 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 100 | $11,879 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 61 | $10,647 | $166 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $8,467 | $86 |
| Test to measure rate of airflow | 191 | $7,590 | $33 |
| Short return visit (20+ min) | 99 | $6,852 | $55 |
| New patient visit (60+ min) | 38 | $6,012 | $158 |
| Test to examine how well the lungs exchange gases | 101 | $5,225 | $47 |
| Test to measure largest amount of air breathed in an out | 146 | $3,541 | $22 |
| Test to determine lung volumes using sensors | 67 | $3,135 | $47 |
| Long return visit (40+ min) | 23 | $2,742 | $110 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 36 | $1,917 | $32 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 11 | $1,369 | $114 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 12 | $1,246 | $104 |
| Short return visit | 11 | $374 | $34 |
2014: 17 services
| Return visit (30+ min) | 200 | $42,320 | $87 |
| Critical care, first 30-74 minutes | 67 | $29,559 | $184 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 75 | $8,751 | $60 |
| Test to measure rate of airflow | 190 | $8,453 | $34 |
| Short return visit (20+ min) | 104 | $7,602 | $57 |
| Test to examine how well the lungs exchange gases | 101 | $5,900 | $49 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,392 | $168 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $5,212 | $87 |
| New patient visit (60+ min) | 22 | $3,861 | $175 |
| Test to measure largest amount of air breathed in an out | 145 | $3,806 | $22 |
| Long return visit (40+ min) | 30 | $3,606 | $116 |
| Test to determine lung volumes using sensors | 47 | $2,246 | $48 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 15 | $1,609 | $107 |
| Sleep study in sleep lab (6 years or older) | 11 | $1,135 | $103 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 23 | $1,117 | $31 |
| Insertion of tube into vena cava | 11 | $1,076 | $98 |
| Ultrasonic guidance for blood vessel access | 17 | $228 | $13 |
2013: 17 services
| Critical care, first 30-74 minutes | 86 | $35,993 | $180 |
| Return visit (30+ min) | 188 | $35,945 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 81 | $11,592 | $58 |
| Short return visit (20+ min) | 112 | $8,279 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 46 | $7,954 | $85 |
| Test to measure rate of airflow | 179 | $7,475 | $35 |
| Test to examine how well the lungs exchange gases | 107 | $6,242 | $54 |
| New patient visit (60+ min) | 38 | $6,037 | $159 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $4,923 | $154 |
| Test to measure largest amount of air breathed in an out | 146 | $3,741 | $23 |
| Test to determine lung volumes using sensors | 68 | $3,652 | $53 |
| Long return visit (40+ min) | 27 | $3,147 | $109 |
| New patient visit (45+ min) | 15 | $2,107 | $140 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 31 | $1,559 | $32 |
| Short return visit | 13 | $549 | $37 |
| Ultrasonic guidance for blood vessel access | 11 | $133 | $12 |
| Test to measure oxygen level in blood using ear or finger device | 28 | $88 | $3 |
Drugs they prescribed that Part D paid
$258,834
Pharmacies billed $258,834 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
441 generic and 488 brand-name prescriptions · $258,834 in drug cost · 74 antibiotic prescriptions to 49 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trelegy Ellipta | 152 | $108,392 | $713 |
| Breo Ellipta | 46 | $28,883 | $628 |
| Anoro Ellipta | 49 | $26,483 | $540 |
| Breztri Aerosphere | 27 | $19,954 | $739 |
| Stiolto Respimat | 20 | $13,489 | $674 |
See all 19 drugs
| Trelegy Ellipta | 152 | $108,392 | $713 |
| Breo Ellipta | 46 | $28,883 | $628 |
| Anoro Ellipta | 49 | $26,483 | $540 |
| Breztri Aerosphere | 27 | $19,954 | $739 |
| Stiolto Respimat | 20 | $13,489 | $674 |
| Arnuity Ellipta | 32 | $9,553 | $299 |
| Symbicort | 20 | $9,511 | $476 |
| Spiriva Handihaler | 15 | $8,226 | $548 |
| Breyna | 31 | $3,826 | $123 |
| Albuterol Sulfate Hfa | 160 | $3,208 | $20 |
| Ventolin Hfa | 29 | $2,135 | $74 |
| Wixela Inhub | 11 | $1,916 | $174 |
| Fluticasone-Salmeterol | 15 | $1,855 | $124 |
| Montelukast | 56 | $415 | $7 |
| Prednisone | 79 | $220 | $3 |
| Cefuroxime | 20 | $192 | $10 |
| Pregabalin | 19 | $179 | $9 |
| Azithromycin | 17 | $75 | $4 |
| Levofloxacin | 11 | $40 | $4 |
Year by year
| 2024 | 929 | 202 | None | 53% | $258,834 |
| 2023 | 850 | 194 | None | 66% | $403,492 |
| 2022 | 777 | 211 | 0% (0) | 62% | $323,795 |
| 2021 | 750 | 208 | None | 67% | $377,133 |
| 2020 | 787 | 196 | None | 69% | $470,773 |
| 2019 | 943 | 227 | 0% (0) | 65% | $394,782 |
| 2018 | 862 | 189 | None | 69% | $350,258 |
| 2017 | 818 | 172 | None | 70% | $437,212 |
| 2016 | 905 | 173 | None | 67% | $458,142 |
| 2015 | 825 | 158 | None | 69% | $368,158 |
| 2014 | 652 | 135 | None | 72% | $210,876 |
| 2013 | 676 | 137 | None | 72% | $221,627 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Trelegy Ellipta | 108 | $94,612 | $876 |
| Anoro Ellipta | 59 | $36,805 | $624 |
| Breo Ellipta | 59 | $32,933 | $558 |
| Spiriva Handihaler | 33 | $21,647 | $656 |
| Stiolto Respimat | 24 | $19,393 | $808 |
| Symbicort | 21 | $17,064 | $813 |
| Spiriva Respimat | 22 | $14,299 | $650 |
| Breztri Aerosphere | 15 | $10,323 | $688 |
| Incruse Ellipta | 22 | $9,338 | $424 |
| Advair Diskus | 14 | $7,953 | $568 |
| Albuterol Sulfate Hfa | 183 | $6,606 | $36 |
| Combivent Respimat | 12 | $6,093 | $508 |
| Flovent Diskus | 13 | $3,990 | $307 |
| Ventolin Hfa | 24 | $1,506 | $63 |
| Montelukast | 36 | $567 | $16 |
| Cefuroxime | 24 | $414 | $17 |
| Prednisone | 37 | $204 | $6 |
| Azithromycin | 13 | $106 | $8 |
2022: 15 drugs
| Trelegy Ellipta | 77 | $64,961 | $844 |
| Breo Ellipta | 62 | $30,236 | $488 |
| Anoro Ellipta | 47 | $29,410 | $626 |
| Symbicort | 39 | $17,247 | $442 |
| Stiolto Respimat | 19 | $14,895 | $784 |
| Wixela Inhub | 34 | $12,787 | $376 |
| Incruse Ellipta | 26 | $11,929 | $459 |
| Flovent Diskus | 23 | $7,512 | $327 |
| Albuterol Sulfate Hfa | 146 | $7,435 | $51 |
| Combivent Respimat | 15 | $7,274 | $485 |
| Fluticasone-Salmeterol | 17 | $3,618 | $213 |
| Montelukast | 49 | $1,012 | $21 |
| Cefuroxime | 27 | $651 | $24 |
| Prednisone | 46 | $320 | $7 |
| Azithromycin | 13 | $84 | $6 |
2021: 18 drugs
| Adempas | 11 | $131,880 | $11,989 |
| Trelegy Ellipta | 77 | $59,794 | $777 |
| Breo Ellipta | 77 | $48,975 | $636 |
| Anoro Ellipta | 51 | $29,261 | $574 |
| Incruse Ellipta | 19 | $10,089 | $531 |
| Symbicort | 19 | $8,732 | $460 |
| Stiolto Respimat | 15 | $8,560 | $571 |
| Spiriva Respimat | 11 | $7,147 | $650 |
| Wixela Inhub | 21 | $7,007 | $334 |
| Fluticasone-Salmeterol | 23 | $5,187 | $226 |
| Albuterol Sulfate Hfa | 102 | $4,934 | $48 |
| Flovent Diskus | 12 | $4,517 | $376 |
| Dulera | 13 | $3,885 | $299 |
| Ventolin Hfa | 33 | $1,939 | $59 |
| Cefuroxime | 17 | $452 | $27 |
| Montelukast | 27 | $326 | $12 |
| Prednisone | 41 | $276 | $7 |
| Azithromycin | 18 | $145 | $8 |
2020: 21 drugs
| Adempas | 14 | $136,883 | $9,777 |
| Breo Ellipta | 83 | $41,178 | $496 |
| Trelegy Ellipta | 60 | $41,105 | $685 |
| Anoro Ellipta | 57 | $29,110 | $511 |
| Symbicort | 35 | $24,191 | $691 |
| Incruse Ellipta | 29 | $12,189 | $420 |
| Advair Diskus | 22 | $11,951 | $543 |
| Wixela Inhub | 28 | $8,789 | $314 |
| Combivent Respimat | 15 | $8,419 | $561 |
| Tudorza Pressair | 14 | $7,885 | $563 |
| Spiriva | 11 | $6,132 | $557 |
| Albuterol Sulfate Hfa | 65 | $3,669 | $56 |
| Arnuity Ellipta | 17 | $3,560 | $209 |
| Ventolin Hfa | 33 | $2,374 | $72 |
| Proair Hfa | 14 | $1,041 | $74 |
| Montelukast | 31 | $567 | $18 |
| Cefuroxime | 14 | $297 | $21 |
| Prednisone | 40 | $238 | $6 |
| Azithromycin | 13 | $139 | $11 |
| Sulfamethoxazole-Trimethoprim | 11 | $70 | $6 |
| Gabapentin | 11 | $68 | $6 |
2019: 23 drugs
| Adempas | 12 | $126,291 | $10,524 |
| Symbicort | 76 | $35,838 | $472 |
| Breo Ellipta | 76 | $35,514 | $467 |
| Trelegy Ellipta | 54 | $35,227 | $652 |
| Advair Diskus | 35 | $27,946 | $798 |
| Anoro Ellipta | 55 | $24,865 | $452 |
| Spiriva | 27 | $19,890 | $737 |
| Incruse Ellipta | 44 | $16,516 | $375 |
| Spiriva Respimat | 20 | $12,033 | $602 |
| Stiolto Respimat | 11 | $7,803 | $709 |
| Wixela Inhub | 28 | $7,488 | $267 |
| Tudorza Pressair | 11 | $5,465 | $497 |
| Proair Hfa | 37 | $3,781 | $102 |
| Ventolin Hfa | 44 | $3,047 | $69 |
| Fluticasone-Salmeterol | 14 | $2,697 | $193 |
| Albuterol Sulfate Hfa | 38 | $2,532 | $67 |
| Arnuity Ellipta | 12 | $2,149 | $179 |
| Montelukast | 76 | $1,150 | $15 |
| Theophylline | 12 | $621 | $52 |
| Cefuroxime | 25 | $478 | $19 |
| Prednisone | 71 | $421 | $6 |
| Azithromycin | 27 | $343 | $13 |
| Levofloxacin | 13 | $234 | $18 |
2018: 18 drugs
| Adempas | 12 | $120,099 | $10,008 |
| Breo Ellipta | 99 | $46,995 | $475 |
| Symbicort | 76 | $34,363 | $452 |
| Advair Diskus | 49 | $32,008 | $653 |
| Anoro Ellipta | 46 | $20,311 | $442 |
| Spiriva | 36 | $19,343 | $537 |
| Incruse Ellipta | 37 | $15,226 | $412 |
| Tudorza Pressair | 16 | $7,705 | $482 |
| Dulera | 19 | $6,920 | $364 |
| Proair Hfa | 69 | $6,011 | $87 |
| Flovent Diskus | 14 | $3,763 | $269 |
| Ventolin Hfa | 57 | $3,599 | $63 |
| Theophylline | 14 | $873 | $62 |
| Montelukast | 42 | $543 | $13 |
| Prednisone | 78 | $501 | $6 |
| Azithromycin | 30 | $327 | $11 |
| Levofloxacin | 12 | $305 | $25 |
| Cefuroxime | 13 | $261 | $20 |
2017: 18 drugs
| Adempas | 12 | $113,868 | $9,489 |
| Esbriet | 11 | $90,297 | $8,209 |
| Advair Diskus | 61 | $34,744 | $570 |
| Breo Ellipta | 66 | $28,005 | $424 |
| Spiriva | 62 | $26,574 | $429 |
| Symbicort | 57 | $25,005 | $439 |
| Incruse Ellipta | 56 | $20,915 | $373 |
| Anoro Ellipta | 35 | $14,710 | $420 |
| Tudorza Pressair | 12 | $5,427 | $452 |
| Proair Hfa | 71 | $5,244 | $74 |
| Qvar | 11 | $4,034 | $367 |
| Flovent Diskus | 12 | $3,530 | $294 |
| Pulmicort Flexhaler | 11 | $2,359 | $214 |
| Ventolin Hfa | 30 | $1,777 | $59 |
| Montelukast | 51 | $773 | $15 |
| Prednisone | 76 | $704 | $9 |
| Azithromycin | 19 | $137 | $7 |
| Amoxicillin-Clavulanate Potass | 11 | $91 | $8 |
2016: 19 drugs
| Adempas | 12 | $109,183 | $9,099 |
| Letairis | 12 | $105,356 | $8,780 |
| Spiriva | 105 | $38,460 | $366 |
| Advair Diskus | 78 | $34,466 | $442 |
| Symbicort | 59 | $23,262 | $394 |
| Breo Ellipta | 44 | $15,263 | $347 |
| Incruse Ellipta | 26 | $9,509 | $366 |
| Tudorza Pressair | 17 | $8,204 | $483 |
| Proair Hfa | 74 | $6,089 | $82 |
| Flovent Diskus | 15 | $3,606 | $240 |
| Ventolin Hfa | 49 | $2,961 | $60 |
| Pulmicort Flexhaler | 12 | $2,417 | $201 |
| Proventil Hfa | 17 | $1,244 | $73 |
| Montelukast | 64 | $1,126 | $18 |
| Cefuroxime | 16 | $563 | $35 |
| Prednisone | 69 | $558 | $8 |
| Levofloxacin | 17 | $397 | $23 |
| Pramipexole Dihydrochloride | 22 | $311 | $14 |
| Azithromycin | 16 | $141 | $9 |
2015: 22 drugs
| Adempas | 14 | $119,166 | $8,512 |
| Letairis | 12 | $92,671 | $7,723 |
| Spiriva | 103 | $37,868 | $368 |
| Advair Diskus | 68 | $28,199 | $415 |
| Symbicort | 77 | $25,860 | $336 |
| Tudorza Pressair | 22 | $8,420 | $383 |
| Breo Ellipta | 28 | $7,627 | $272 |
| Proair Hfa | 73 | $6,818 | $93 |
| Combivent Respimat | 18 | $6,345 | $353 |
| Dulera | 20 | $5,108 | $255 |
| Asmanex | 19 | $4,496 | $237 |
| Alvesco | 13 | $3,486 | $268 |
| Flovent Diskus | 15 | $2,954 | $197 |
| Ventolin Hfa | 22 | $1,311 | $60 |
| Montelukast | 59 | $1,120 | $19 |
| Cefuroxime | 20 | $929 | $46 |
| Proventil Hfa | 11 | $735 | $67 |
| Prednisone | 52 | $344 | $7 |
| Theophylline Anhydrous | 17 | $326 | $19 |
| Pramipexole Dihydrochloride | 12 | $301 | $25 |
| Azithromycin | 20 | $170 | $9 |
| Fluticasone Propionate | 14 | $150 | $11 |
2014: 18 drugs
| Letairis | 12 | $86,848 | $7,237 |
| Spiriva | 100 | $33,352 | $334 |
| Advair Diskus | 41 | $17,237 | $420 |
| Symbicort | 49 | $14,870 | $303 |
| Combivent Respimat | 24 | $8,262 | $344 |
| Tudorza Pressair | 13 | $7,226 | $556 |
| Breo Ellipta | 21 | $5,483 | $261 |
| Proair Hfa | 59 | $4,662 | $79 |
| Flovent Diskus | 18 | $4,361 | $242 |
| Asmanex | 18 | $3,454 | $192 |
| Dulera | 12 | $2,779 | $232 |
| Nasonex | 15 | $2,531 | $169 |
| Montelukast | 47 | $1,694 | $36 |
| Ventolin Hfa | 20 | $1,011 | $51 |
| Cefuroxime | 12 | $484 | $40 |
| Prednisone | 49 | $289 | $6 |
| Azithromycin | 20 | $235 | $12 |
| Pramipexole Dihydrochloride | 11 | $219 | $20 |
2013: 17 drugs
| Letairis | 12 | $81,273 | $6,773 |
| Spiriva | 103 | $31,886 | $310 |
| Advair Diskus | 65 | $25,390 | $391 |
| Symbicort | 52 | $16,623 | $320 |
| Proair Hfa | 68 | $6,472 | $95 |
| Tudorza Pressair | 15 | $6,216 | $414 |
| Combivent | 19 | $5,763 | $303 |
| Flovent Diskus | 15 | $4,115 | $274 |
| Flovent Hfa | 11 | $2,561 | $233 |
| Daliresp | 11 | $2,206 | $201 |
| Asmanex | 12 | $1,987 | $166 |
| Pulmicort Flexhaler | 11 | $1,764 | $160 |
| Nasonex | 12 | $1,726 | $144 |
| Montelukast | 42 | $1,385 | $33 |
| Azithromycin | 33 | $562 | $17 |
| Prednisone | 40 | $233 | $6 |
| Omeprazole | 12 | $165 | $14 |
Money from drug and device companies
$101 in 2025
| 2025 | 2 | 4 | None | $101 |
| 2024 | 2 | 4 | None | $128 |
| 2023 | 3 | 3 | None | $126 |
| 2022 | 5 | 5 | None | $145 |
| 2021 | 1 | 2 | None | $44 |
| 2019 | 2 | 3 | None | $87 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Inspire Medical Systems | Inspire | $57 | 2 payments
|
| Insmed | Arikayce | $44 | 2 payments
|
See all 4 published payments
| Insmed | Meals · 2025-09-19 | Arikayce | $19 |
| Insmed | Meals · 2025-09-16 | Arikayce | $25 |
| Inspire Medical Systems | Meals · 2025-09-09 | Inspire | $15 |
| Inspire Medical Systems | Meals · 2025-06-11 | Inspire | $42 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $128
| Inspire Medical Systems | Inspire | $99 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $29 | 1 payment
|
2023: $126
| Biotronik | Orsiro Mission | $74 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $32 | 1 payment
|
| Inspire Medical Systems | Inspire | $20 | 1 payment
|
2022: $145
| Baxter Healthcare | Hillrom - Life 2000 Ventilation System | $38 | 1 payment
|
| Boston Scientific | Lux-Dx Insertable Cardiac Monitor | $35 | 1 payment
|
| Electromed | Smartvest | $33 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $26 | 1 payment
|
| Gilead Sciences | Veklury | $14 | 1 payment
|
2021: $44
| GlaxoSmithKline | Trelegy Ellipta | $44 | 2 payments
|
2019: $87
| Boehringer Ingelheim Pharmaceuticals | Ofev | $69 | 2 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $18 | 1 payment
|
Professional record
- NPI
- 1932205119
- Licence
- CA G65091California G65091: Current · expires 2028-04-30
- Trained
- Temple University School of Medicine, 1987 · 39 years ago
- Group
- Community Memorial Health System · Ventura Pulmonary and Critical Care Medical Group
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0200X (207RC0200X); Federal specialty code 207RP1001X (207RP1001X)
- Mailing address
- 168 N Brent St, 406, Ventura, CA, 93003
- NPI first listed
- 2006-09-15
- NPI last updated
- 2025-09-11
This is when the NPI record was last certified, not a medical board exam.